Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

Stefan Wirth, Philip Rosenthal, Regino P. Gonzalez-Peralta, Maureen M. Jonas, William F. Balistreri, Chuan Hao Lin, Winita Hardikar, Kathryn Kersey, Benedetta Massetto, Bittoo Kanwar, Diana M. Brainard, Jiang Shao, Evguenia Svarovskaia, Brian Kirby, Ronen Arnon, Karen F. Murray, Kathleen B. Schwarz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection'. Together they form a unique fingerprint.

Medicine & Life Sciences